(Q68966386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

review article

1 reference

title

Biology of Pseudomonas aeruginosa in relation to pulmonary infection in cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

Pseudomonas aeruginosa

1 reference

Pitt TL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

language of work or name

English

0 references

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

Journal of the Royal Society of Medicine

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

79 Suppl 12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

13-18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

Mucoid Variation in Pseudomonas AeruginosaInduced by the Action of Phage

28 September 2019

cites work

1 reference

12 December 2020

PRODUCTION OF ELASTASE AND PROTEINASE BY PSEUDOMONAS AERUGINOSA

1 reference

12 December 2020

Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum

1 reference

12 December 2020

Treatment of pulmonary infections in patients with cystic fibrosis: A comparative study of ticarcillin and gentamicin

1 reference

12 December 2020

Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis

1 reference

12 December 2020

Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages

1 reference

12 December 2020

Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid form to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro

1 reference

12 December 2020

Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay

1 reference

12 December 2020

Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis

1 reference

12 December 2020

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

1 reference

12 December 2020

Role of pili in adherence of Pseudomonas aeruginosa to mammalian buccal epithelial cells

1 reference

12 December 2020

Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis

1 reference

12 December 2020

The penetration of antibiotics through sodium alginate and through the exopolysaccharide of a mucoid strain of Pseudomonas aeruginosa

1 reference

12 December 2020

Heterogeneity of antibiotic resistance in mucoid isolates of Pseudomonas aeruginosa obtained from cystic fibrosis patients: role of outer membrane proteins

1 reference

12 December 2020

Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo

1 reference

12 December 2020

Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa

1 reference

12 December 2020

Bacteriophages in sputum of patients with bronchopulmonary Pseudomonas infections.

1 reference

12 December 2020

Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination

1 reference

12 December 2020

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

1 reference

12 December 2020

State of the art: typing Pseudomonas aeruginosa

1 reference

12 December 2020

Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin

1 reference

12 December 2020

Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

1 reference

12 December 2020

Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa

1 reference

12 December 2020

The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis

1 reference

12 December 2020

Inhaled antibiotics in cystic fibrosis

1 reference

12 December 2020

Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains

1 reference

12 December 2020

Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis

1 reference

12 December 2020

Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis

1 reference

12 December 2020

Bactericidal activity of serum from cystic fibrosis patients for Pseudomonas aeruginosa

1 reference

12 December 2020

Heterogeneity and reduction in pulmonary clearance of mucoid Pseudomonas aeruginosa

1 reference

12 December 2020

The role of exotoxin A in pseudomonas disease and immunity.

1 reference

12 December 2020

Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.

1 reference

12 December 2020

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

12 December 2020

Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa

1 reference

12 December 2020

Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis

1 reference

12 December 2020

Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin

1 reference

12 December 2020

Mucoid conversion by phages of Pseudomonas aeruginosa strains from patients with cystic fibrosis

1 reference

12 December 2020

Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results

1 reference

12 December 2020

Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction

1 reference

12 December 2020

IgG proteolytic activity of Pseudomonas aeruginosa in cystic fibrosis.

1 reference

12 December 2020

Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera

1 reference

12 December 2020

Inhibition of Pseudomonas aeruginosa from cystic fibrosis by selective media

1 reference

12 December 2020

Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2425090%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

PubMed publication ID

2425090

1 reference